How Aging Blood Vessels Trigger the Peptide CGRP to Cause Skin Aging Through Immune Cell Activation

Using an endothelial cell-specific senescent mouse model, researchers identified a novel neuroimmune pathway driving intrinsic skin aging. Senescent endothelial cells secrete pro-inflammatory SASP factors that activate dermal neurons to produce calcitonin gene-related peptide (CGRP). This CGRP triggers mast cell degranulation through a non-IgE-mediated pathway, leading to dermal thinning, collagen degradation, and delayed wound healing. Pharmacological stabilization of mast cells or inhibition of the EC-SASP-CGRP pathway significantly attenuated all three hallmarks of intrinsic skin aging.

The researchers created an endothelial cell-specific senescent mouse model to study vascular contributions to skin aging. They tracked the cascade from senescent endothelial cells through neuronal activation to mast cell degranulation. They used pharmacological interventions to stabilize mast cells and inhibit the CGRP pathway, measuring outcomes of dermal thickness, collagen integrity, and wound healing capacity.

This study reveals that skin aging isn't just about what happens in skin cells — it starts with aging blood vessels that set off a chain reaction involving nerves, peptides, and immune cells. This opens up entirely new therapeutic targets: instead of treating skin aging at the surface, interventions could target the underlying CGRP-mast cell axis to prevent or reverse aging from within.

CGRP is already a well-known therapeutic target — CGRP-blocking antibodies are approved for treating migraines. This study reveals an entirely new role for CGRP in driving skin aging through neuroimmune interactions. It suggests that the same class of anti-CGRP drugs used for migraines might have anti-aging applications for skin, and more broadly, that vascular senescence may drive aging in multiple organ systems through similar peptide-mediated pathways.

This study was conducted entirely in mice, and results may not directly translate to human skin aging. The mouse model used engineered endothelial cell senescence, which may not fully replicate natural aging processes. The study focused on intrinsic (age-related) skin aging and did not address extrinsic factors like UV exposure. Long-term effects of blocking the CGRP pathway on skin health are unknown.